CD4 and hepatocellular carcinoma: A study (108) involving the measurement of the number of circulating and liver-resident CD4+CD25+ Tregs in patients with CHB and individuals with HCC showed that the frequency of circulating CD4+CD25+ Tregs did not differ significantly between them.